St. Baldricks Foundation

Request Ticket // Limit: 1* (additional application possible for cancer types specified below) // Tickets Available: 1

Limiting Language

• Institutions may submit only one new fellowship application per year, with the exception noted in the next bullet allowing a possible second application. (Concurrent fellows with different funding periods are allowed.) 
• ATTENTION: limited submissions policy exception:  Due to high interest from donors and low numbers of past applications, a second Fellow application will be accepted only if focused on one of the following:   
  • Brain tumors – all types, including rare forms, especially atypical teratoid/rhabdoid tumor (AT/RT), diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG), and glioblastoma (GBM) 
  • Burkitt lymphoma – all types, especially sporadic 
  • Rhabdoid tumors - Extrarenal 
• NOTE: This exception to the limited submissions policy is valid whether or not your institution took advantage of the exception in another grant cycle. 

Program Overview/Select Eligibility Criteria
St. Baldrick’s Fellowships are granted for two (2) years of pediatric oncology fellowship training, with an opportunity for one (1) additional year of funding based upon need, significant accomplishment, and approved application. 

• During each grant cycle, an applicant can only apply once as the lead Principal Investigator.  
• Institutions must be located in the United States. 
• Applicants need not be American citizens; however, they must work at an academic, medical, or non-profit research institution within the United States. 
• Applicants from the NCI/NIH are not eligible to apply for St. Baldrick’s Fellowship Awards. 
• For Fellowship Awards, a program/institution is defined by the institution’s American Board of Pediatrics approved fellowship program in Pediatric Hematology/Oncology.  
• St. Baldrick’s funds may not be used for human embryonic stem cell research.
• Fellowship Awards are limited to salary and fringe benefits for the Fellow. • Applicants should hold an M.D. or D.O. degree by the date the grant becomes effective. 
• Applicant should be in their 2nd or 3rd year of pediatric oncology fellowship by July 1, 2027. Exceptions are allowed for a research residency format (2 years of residency 4 years of fellowship).  
  • If the applicant fits a research residency format exception, please state this in the applicant eligibility statement in the Letter of Intent. 
• Applicants may not hold an appointment of assistant professor or above. 
• Applicants must have a fellowship mentor who provides supervision, facilities, and research support at an American Board of Pediatrics approved fellowship program in Pediatric Hematology/Oncology. 
  • A co-mentor is allowed. 

The full request for proposals is linked here. 

No Applicants // Limit: 1 // Tickets Available: 1

These grants are not for a specific research project, but rather for personnel (i.e., a clinical research associate) or resources to allow more research to be done. These grants are intended for institutions with the potential to participate significantly more in childhood cancer clinical trials, but which are smaller or have barriers to greater participation due to a lack of resources. Applications to support Clinical Research Associate (CRA) type positions are preferred. Preference is given to institutions with high needs and low philanthropic support in geographical areas where St. Baldrick’s funds are raised. Institutions which do not currently receive other St. Baldrick’s grants are also given preference. (Grant will be $25,000–$50,000.)  

For full eligibility criteria, please see the RFA.

No Applicants // Limit: 1* // Tickets Available: 1

* ATTENTION: limited submissions policy exception:  Due to high interest from donors and low numbers of past applications, a second Fellow application will be accepted only if focused on one of the following: 

• Brain tumors – all types, including rare forms, especially atypical teratoid/rhabdoid tumor (AT/RT), diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG), and glioblastoma (GBM)
• Burkitt lymphoma – all types, especially sporadic
• Rhabdoid tumors - Extrarenal 
   

Fellowship Duration

St. Baldrick’s Fellowships are granted for two (2) years of pediatric oncology fellowship training, with an opportunity for one (1) additional year of funding based upon need, significant accomplishment, and approved application. 

Eligibility 

For full eligibility, please see the RFA.